Development of Novel Major Histocompatibility Complex Class I and Class II-Deficient NOD-SCID IL2R Gamma Chain Knockout Mice for Modeling Human Xenogeneic Graft-Versus-Host Disease-Reference-Cited by-同舟云学术

Development of Novel Major Histocompatibility Complex Class I and Class II-Deficient NOD-SCID IL2R Gamma Chain Knockout Mice for Modeling Human Xenogeneic Graft-Versus-Host Disease

Published:2006-11-06 Issue: Volume: Page:105-117
ISSN:1064-3745
Container-title:Methods in Molecular Biology
language:
Short-container-title:

Author:

Pino Steve,Brehm Michael A.,Covassin-Barberis Laurence,King Marie,Gott Bruce,Chase Thomas H.,Wagner Jennifer,Burzenski Lisa,Foreman Oded,Greiner Dale L.,Shultz Leonard D.

Publisher

Humana Press

Link

http://link.springer.com/content/pdf/10.1007/978-1-60761-058-8_7.pdf

Reference35 articles.

1. Alderuccio, F., Siatskas, C., Chan, J., Field, J., Murphy, K., Nasa, Z. and Toh, B. H. (2006). Haematopoietic stem cell gene therapy to treat autoimmune disease. Curr. Stem Cell Res. Ther. 1: 279–287.

2. Passweg, J. and Tyndall A. (2007). Autologous stem cell transplantation in autoimmune diseases. Semin. Hematol. 44: 278–285.

3. Ringden, O. and Le Blanc, K. (2005). Allogeneic hematopoietic stem cell transplantation: state of the art and new perspectives. APMIS 113: 813–830.

4. Welniak, L. A., Blazar B. R. and Murphy W. J. (2007). Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu. Rev. Immunol. 25: 139–170.

5. Demirer, T., Barkholt, L., Blaise, D., Pedrazzoli, P., Aglietta, M., Carella, A. M., Bay, J. O., Arpaci, F., Rosti, G., Gurman, G., Niederwieser, D. and Bregni, M. (2008). Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors. Nat. Clin. Pract. Oncol. 5: 256–267.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Against all odds: The road to success in the development of human immune reconstitution mice;Animal Models and Experimental Medicine;2024-04-09

2. T-cell development and activation in humanized mice lacking mouse major histocompatibility complexes;2024-04-02

3. Progress in construction of mouse models to investigate the pathogenesis and immune therapy of human hematological malignancy;Frontiers in Immunology;2023-08-14

4. Humanized mouse models with endogenously developed human natural killer cells for in vivo immunogenicity testing of HLA class I-edited iPSC-derived cells;Biochemical and Biophysical Research Communications;2023-06

5. Autologous humanized mouse models to study combination and single-agent immunotherapy for colorectal cancer patient-derived xenografts;Frontiers in Oncology;2022-09-21